Dr Andrew Chan appointed as Scientific Advisory Board Chair
Founded in 1974, the International Aspirin Foundation shares information and stimulates research interest and discussion about all aspects of aspirin and acetylsalicylic acid.
Scientific Advisory Board
Key Features
Scientific Conference
The International Aspirin Foundation has today announced that Dr Andrew Chan will become Chair of its Scientific Advisory Board. Dr Chan succeeds Professor Carlo Patrono who will retire from the role, having led the Board since 2017.
For further details see our News section.
The International Aspirin Foundation’s next Scientific Conference will celebrate 125 years of aspirin.
Please find more information regarding the Scientific Conference here.
Tickets can be found below.
Professor Patrono’s research has brought clinical benefit to many millions of people worldwide. In this interview with Pennie Taylor, health journalist, he reflects on a distinguished career; aspirin’s long legacy and its promising prospects. Reminding us that platelets are key, because that’s what aspirin does; its job at low doses is to selectively acetylate that single amino acid, of that single platelet protein, due to that simple chemical modification that Felix Hoffmann introduced 125 years ago.
Professor Patrono discusses the role of platelets and aspirin’s therapeutic role past, present and future. He also speaks about his pride in having been able to convince clinical investigators in the cardiology and neurology field to initiate clinical trials to test the efficacy and safety of low dose aspirin. Click here to access the key paper.
Dr Helga Helgadottir presented at the Emerging Aspirin Investigator awards in October 2021, watch her presentation above.
Contributions from the research community shared here are unsolicited and are not peer reviewed. We encourage sharing information and stimulating research interest, but we do not endorse or approve the submission. See full disclaimer
Mervyn Vergouwen, MD PhD,
Professor Mazzeffi.
Sign up to be part of the aspirin community and be the first to receive latest information.
Have something to say about aspirin?
Have something to say about aspirin?
Please fill in the form below and we will contact you with further information.
Have something to say about aspirin?
We would like to hear from you and have a chat, and maybe feature you on our podcast. Please fill in the form below and we will contact you with further information.
Adjunct Associate Professor DUKE-NUS Graduate Medical School,
Consultant Oncologist Curie Oncology Singapore,
Visiting Consultant National Cancer Centre Singapore.
Medical Oncology
In the past 3 years, I have received consultant fees from Tessa Therapeutics, Aslan Pharmaceuticals, Novartis, and AstraZeneca.
I received grant support for investigator-initiated research from:
I hold shares in: Roche, BMS, AstraZeneca, Incyte, Teva Pharmaceuticals, Trillium Therapeutics, Compugen, Arrowhead pharmaceuticals, Emergex, QuantumDx and Halozyme Therapeutics
I received consultant and speakers fees from Amgen, AstraZeneca, Bayer, Lilly and Sanofi.
Junbo Ge
Ge Junbo, male, was born in Wulian, Shandong province on Nov. 8, 1962. He is the member of Chinese Academy of Sciences, professor and doctoral supervisor. He received his doctor’s degree of Medicine from German Mayence University in 1993 and now works as the director for Shanghai Institute of Cardiovascular Disease and the Center for Stem Cells and Tissue Engineering, Fudan University. He is also the designate chairman of the Cardiovascular Disease Branch of Chinese Medical Association, council member of the Cardiovascular Angiography and Interventions Association, international consultant of the American Heart Association. In Dec. 2013, he was appointed as the vice president of Tongji University.
Prof. Ge has been engaged in clinical and scientific research work of cardiovascular disease since 1987, and his research area covers the pathogenesis of coronary heart disease, early diagnosis and treatment plan optimization.
AACR Honors Dr. Andrew T. Chan With 2019 AACR-Waun Ki Hong Award
Click here to find the press release.
I received consultant Bayer and Pfizer, Inc.
I received grant support for investigator-initiated research from:
Professor of Medicine, Harvard Medical School; Chief Division of Aging, Brigham and Women’s Hospital; Director of Preventive Cardiology and Director of Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System.
Discipline: Cardiology and Epidemiology
I received consultant and speaker fees Bayer.
I received grant support as a principal investigator or co-investigator for research from the VA, DOD, NIH, Merck and Kowa.
Pierre Amarenco, MD, FAHA, FAAN
Neurology and Vascular Neurology
N/A
I received consultant and speakers fees from Acticor Biotech, Amgen, Bayer, GlaxoSmithKline, Tremeau, Zambon.
I received grant support for investigator-initiated research from: